Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia
- PMID: 28114533
- DOI: 10.1001/jama.2016.16535
Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia
Abstract
Clinical question: Are antifungal agents associated with lower rates of mortality and invasive fungal infections when administered before definitive diagnosis of an invasive fungal infection in critically ill patients without neutropenia?
Bottom line: Antifungal treatment administered prior to diagnosis of an invasive fungal infection is not associated with either higher or lower rates of all-cause mortality. Antifungal treatment in this setting is associated with lower rates of invasive fungal infections compared with placebo or no intervention in critically ill patients without neutropenia, but the quality of the evidence is low.
Comment on
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004920. doi: 10.1002/14651858.CD004920.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2016 Jan 16;(1):CD004920. doi: 10.1002/14651858.CD004920.pub3. PMID: 16437504 Updated.
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3. Cochrane Database Syst Rev. 2016. PMID: 26772902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical